Drug Efficacy Study in the STAM™ Model Published in Translational Oncology
- 2022.07.20
- PUBLICATION
SMC is proud to announce that Kurume University (JPN) has published the results of their study using our STAM™ model in Translational Oncology.
Title "Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments"
In this study, the authors evaluated the anti-tumor effect of combining sorafenib and S-1, a chemotherapeutic agent, in the STAM™ model.
As demonstrated in this paper, it is possible to study the effects of your compound in the STAM™ model as both a monotherapy as well as in combination therapy.
For detailed information, see the below URL.
Additionally, we can also suggest studies based on our many years of experience in both the STAM™ model, as well in other models, so please do not hesitate to contact us if you would like to learn more.
■About our STAM™ model mouse